The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 trial of oral EPI-7386 (masofaniten) in combination with enzalutamide (Enz) compared to Enz alone in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase 1 (P1) results and phase 2 (P2) design.
 
Christos Kyriakopoulos
Stock and Other Ownership Interests - Biogen; Epic Systems (I)
Consulting or Advisory Role - AVEO; EMD Serono; Exelixis; Janssen Oncology; Janssen Oncology; Sanofi
Research Funding - AstraZeneca; ESSA; Gilead Sciences; Pionyr; Sanofi
 
Gurkamal S. Chatta
Consulting or Advisory Role - Cardinal Health
Research Funding - Abbvie (Inst); Taiho Oncology (Inst)
Travel, Accommodations, Expenses - Cardinal Health
 
Andrew Leonard Laccetti
Consulting or Advisory Role - Bayer; Guidepoint Global; Third Bridge
Research Funding - Bayer; ESSA; Johnson & Johnson/Janssen
 
Nicholas Iannotti
No Relationships to Disclose
 
Alexandra Sokolova
No Relationships to Disclose
 
Sebastien J. Hotte
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Scientific and Medical Affairs Inc; Bayer; BMS; Eisai; Ipsen; Janssen Oncology; Merck
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Pfizer; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); ESSA (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SignalChem (Inst)
 
Ronald F. Tutrone
Employment - Chesapeake Urology
Stock and Other Ownership Interests - Compass Therapeutics; GlaxoSmithKline; Myovant Sciences; Novartis; Nymox; Veru
Consulting or Advisory Role - Exosome Diagnostics; Myovant Sciences; Novartis; Nymox
Speakers' Bureau - Exosome Diagnostics; Medivation/Astellas; Pfizer
Research Funding - Advantagene (Inst); Bayer (Inst); Dendreon (Inst); Exosome Diagnostics (Inst); Genomic Health (Inst); Janssen Oncology (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Merck (Inst); POINT Biopharma (Inst); Veru (Inst)
 
Mark Christopher Markowski
No Relationships to Disclose
 
Luke T. Nordquist
No Relationships to Disclose
 
Roberto Pili
Consulting or Advisory Role - Amarex/Allarity
Research Funding - Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Merck (Inst); Syndax (Inst)
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Bayer; Dendreon; EMD Serono; Pfizer; Sanofi; Sanofi/Aventis; Seagen
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Dendreon; EMD Serono; Pfizer
Speakers' Bureau - AstraZeneca; Dendreon; Sanofi; Seagen
 
Karen Villaluna
Employment - ESSA; Surrozen (I)
Stock and Other Ownership Interests - ESSA
Travel, Accommodations, Expenses - ESSA
 
Brett Younginger
Employment - ESSA
Stock and Other Ownership Interests - ESSA
 
Ronan Le Moigne
Employment - ESSA
Stock and Other Ownership Interests - ESSA
 
Alessandra Cesano
Employment - ESSA
Stock and Other Ownership Interests - ESSA